Donald G. Catanzaro

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Assistant Professor

University of Arkansas primary UA Little Rock

Also affiliated: California Department of Public Health (2016); San Diego State University (2013–2014); University of California San Diego (2012–2018); ET Enterprises (United Kingdom) (2011); San Francisco Department of Public Health (2018); Total (United States) (2011); Health and Human Services Agency (2018); San Joaquin County Public Health Services (2018); Santa Clara County Behavioral Health Services (2018)

Faculty Researcher

22 h-index 59 pubs 2,067 cited

Research Areas

Biomedical Subjects

Links

ORCID Lab Website

OverviewAI-generated summary

Donald G. Catanzaro's research focuses on the development and evaluation of diagnostic tools and biomarkers for mycobacterial infections, particularly tuberculosis (TB).

His work includes studies on novel detection methods for circulating cell-free DNA of *Mycobacterium tuberculosis* in both adults and children, including those with HIV. Catanzaro investigates T cell epitopes and blood transcriptomic signatures associated with TB infection and treatment response, aiming to identify individuals at risk of developing active disease. He has also explored the potential of circulating mitochondrial cell-free DNA as a biomarker for mycobacterial pulmonary infections and has worked on predictive models for TB treatment outcomes using machine learning. Additionally, his research involves evaluating the performance of diagnostic assays, such as the Cepheid Xpert *Mycobacterium tuberculosis* Host Response Cartridge, in specific populations.

Catanzaro's publication record demonstrates a consistent engagement with advancements in molecular diagnostics, host response characterization, and predictive analytics within the field of infectious diseases. His work has contributed to the understanding of TB pathogenesis and the development of strategies for improved diagnosis and management.

Metrics

h-index: 22
Publications: 59
Citations: 2,067

Selected Publications

Microbial Biomarkers of Tuberculosis Infection and Disease in Blood: Systematic Review and Meta-Analysis (2026)

SSRN Electronic Journal DOI OpenAlex
Microbial biomarkers of tuberculosis infection and disease in blood: systematic review and meta-analysis (2026)

medRxiv DOI OpenAlex
Minimal immune cell subset differences in a cohort of close contacts of tuberculosis index cases (2025)

Tuberculosis DOI OpenAlex
Minimal immune cell subset differences in a cohort of close contacts of tuberculosis index cases (2025)

bioRxiv (Cold Spring Harbor Laboratory) DOI OpenAlex
Quantifying uncertainty in deep learning binary classification with discrete noise in inputs for risk-based decision making (2025)

IISE Transactions 3 citations DOI OpenAlex
Rapid tuberculosis diagnosis from respiratory or blood samples by a low cost, portable lab-in-tube assay (2025)

Science Translational Medicine 33 citations DOI OpenAlex
Understanding tuberculosis transmission and progression: A prospective cohort study of index cases and close contacts in Moldova (2024)

PLoS ONE 4 citations DOI OpenAlex
Prospective Exploratory Evaluation of Cepheid Xpert <i>Mycobacterium tuberculosis</i> Host Response Cartridge: A Focus on Adolescents and Young Adults (2024)

Clinical Infectious Diseases 5 citations DOI OpenAlex
Asynchronous Video Directly Observed Therapy to Monitor Short-Course Latent Tuberculosis Infection Treatment: Results of a Randomized Controlled Trial (2024)

Open Forum Infectious Diseases 4 citations DOI OpenAlex
Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection (2024)

Nature Communications 37 citations DOI OpenAlex
Predicting stringent QuantiFERON-TB Gold Plus conversions in contacts of tuberculosis patients (2023)

Journal of Microbiology Immunology and Infection 5 citations DOI OpenAlex
Identification of differentially recognized T cell epitopes in the spectrum of <i>Mtb</i> infection (2023)

bioRxiv (Cold Spring Harbor Laboratory) 3 citations DOI OpenAlex
Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort (2023)

Journal of Clinical Microbiology 4 citations DOI OpenAlex
1539. A Nine-Gene Blood-Based Signature Meets the World Health Organization Target Product Profiles for Diagnosis of Active Tuberculosis and Predicting Progression from Latent to Active Disease (2022)

Open Forum Infectious Diseases 2 citations DOI OpenAlex
Circulating mitochondrial cell-free DNA dynamics in patients with mycobacterial pulmonary infections: Potential for a novel biomarker of disease (2022)

Frontiers in Immunology 11 citations DOI OpenAlex